Texas Engineers Develop World’s Smallest Fiber Probe for Real-Time Multi-Biomarker Metabolic Tracking

The 1.1mm fiber probe tracks glucose, lactate, and ethanol simultaneously, offering a faster alternative to traditional blood tests in critical care.

By: AXL Media

Published: Apr 23, 2026, 4:55 AM EDT

Source: Information for this report was sourced from EurekAlert!

A Miniature Breakthrough in Continuous Metabolic Surveillance

Engineers at the University of Texas at Austin have successfully developed a record-breaking fiber optic probe designed to revolutionize how clinicians monitor internal body chemistry. Measuring only 1.1 millimeters in diameter, the device is currently the smallest of its kind and is capable of tracking three vital biomarkers—glucose, lactate, and ethanol—at the same time. According to Tanya Hutter, a professor in the Cockrell School of Engineering and lead author of the study, this compact solution allows for a comprehensive view of a patient’s metabolic state in real time. The innovation addresses a long-standing need for faster, minimally invasive tools that can guide medical decisions during the critical windows of emergency care.

The Functional Necessity of Simultaneous Biomarker Detection

The selection of glucose, lactate, and ethanol as target molecules serves specific clinical priorities ranging from diabetes management to the detection of life-threatening conditions. While glucose is a standard metric for metabolic health, elevated lactate levels often serve as an early warning for sepsis or tissue hypoxia, conditions where every second of delay can be fatal. Furthermore, the ability to track ethanol continuously is vital for managing alcohol intoxication, liver injuries, and addiction treatments. Traditionally, these markers required separate tests or invasive fluid collection, but this new fiber probe streamlines the process by capturing a holistic physiological snapshot through a single, tiny insertion point.

Surpassing the Technological Limitations of Microdialysis

For decades, microdialysis has been the standard for measuring small molecules within tissue, particularly in patients suffering from severe traumatic brain injuries. However, this older method is notoriously labor-intensive and suffers from a significant time lag, as samples must be extracted and analyzed offline. The new Texas-engineered probe bypasses these delays by measuring biomarkers directly within the tissue using light. Tse-Ang Lee, a doctoral student and co-author of the research, noted that the probe does not disturb the local environment, providing a more accurate representation of the body's internal chemistry without the need for constant fluid removal and processing.